BlackRock, MGX Make $40 Billion Bet on AI Boom With Aligned Data Centers Deal
Scientists from Tufts create weight-loss drug dubbed 'next Ozempic' that's twice as effective and has fewer side effects (affects not only GLP-1 and GIP, but also glucagon and peptide YY)
GIP, KKR Among Firms Eyeing Stake in Cellnex’s Polish Unit